Angew. Chem. Int. Ed.http://doi.org/fz8rxc (2012)
The therapeutic potential of mesenchymal stem cells (MSCs) is known to be enhanced by their formation into enlarged spheroids of cells. In the centre of these spheroids, as a consequence of a reduced supply of oxygen and nutrients, however, hypoxic conditions can be present. These conditions decrease MSC survival and lower the efficacy of MSC-based therapy involving spheroid transplantation. Now, Younan Xia and colleagues show that the anti-apoptotic activity of human MSCs (hMSCs) can be enhanced by the intracellular delivery of polyplexes composed of the biodegradable polymer, branched poly(disulphide amine) (PDA), and Fas-silencing small interfering RNA (Fas siRNA). These Fas-silenced hMSCs are cultured as enlarged spheroids under hypoxic conditions and the gene-silencing efficiency of the polyplexes is about 1.5 times higher than hMSCs treated with polyplexes formed from Fas siRNA and polyethylenimine. Also, the expression of angiogenic and anti-apoptotic growth factors is increased in the spheroids treated with the Fas siRNA–PDA polyplex.
Rights and permissions
About this article
Cite this article
Stoddart, A. Spheroid survival. Nature Mater 11, 1002 (2012). https://doi.org/10.1038/nmat3512
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmat3512